Strategies for the Protection of Pregnant Women and Infants Against Infectious Diseases (R01)

The summary for the Strategies for the Protection of Pregnant Women and Infants Against Infectious Diseases (R01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.
Federal Grant Title: STRATEGIES FOR THE PROTECTION OF PREGNANT WOMEN AND INFANTS AGAINST INFECTIOUS DISEASES (R01)
Federal Agency Name: National Institutes of Health
Program Name: Allergy, Immunology and Transplantation Research
Grant Categories: Health
CFDA Number: 93.855
Funding Opportunity Number: RFA-AI-11-036
Posted Date: May 27, 2011
Creation Date: Jul 22, 2011
Original Application Deadline: Oct 13, 2011
Current Application Deadline: Oct 13, 2011
Archive Date: Nov 13, 2011
Total Program Funding: $2,900,000
Maximum Federal Grant Award: $350,000
Minimum Federal Grant Award: Information not provided
Expected Number of Awards: 8
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components of U.S. Organizations are allowed.
Grant Description
The purpose of this FOA is to encourage new and innovative mechanistic studies of pathogens that impact placental function and fetal well-being, with the long-term goal of informing the development of interventions against these pathogens and reducing the burden of infection-related pregnancy loss and infant morbidity and mortality.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/rfa-ai-11-036.html
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Pharmacological Approaches to Evaluating Drug Regimens to Address Antimicrobial Resistance...
Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)
Drug Target Development and Validation for Antimicrobial-Resistant Pathogens (R21/R33)
NIAID Clinical Trial Implementation Cooperative Agreement (U01)
NIAID Clinical Trial Implementation Grant (R01)
Center for HIV/AIDS Vaccine Immunology (CHAVI)
Genomics of Transplantation Cooperative Research Program
Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health
NIAMS Clinical Trial Outcome Instrument Development Grant Program (U01)
Biophysical and Biomechanical Aspects of Embryonic Development (R01)
Biophysical and Biomechanical Aspects of Embryonic Development (R21)
Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agricultural...
MARC Undergraduate Student Training in Academic Research (U-STAR) National Research Servic...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2013 FederalGrants.com